## Abstract ## Aims We evaluated a putative central inhibitory effect of intravesical botulinum toxin A (BoNT‐A) on the activity of lumbosacral spinal neurons in a chronic spinal cord injury (SCI) model of bladder overactivity. ## Methods Female Sprague‐Dawley rats underwent T8 spinal cord trans
Effectiveness of botulinum toxin type A against painful limb myoclonus of spinal cord origin
✍ Scribed by Kathleen B. Polo; Dr. Bahman Jabbari
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 319 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Botulinum toxin is now an established treatment for blepharospasm, hemifacial spasm, spasmodic torticollis, and spastic dysphonia. We report the effectiveness of botulinum toxin against painful limb myoclonus of spinal cord origin. The patient, a 16‐year‐old girl with a pulmonary vascular anomaly, Scimitar syndrome, suffered from an acute spinal cord infarct at age 11. She was left with paralysis of the right leg and bladder dysfunction. Four years after the original insult, she developed “painful cramping” and involuntary movements of the left thigh, which were unresponsive to a wide range of therapeutic trials. The movements were continuous, rhythmic, and confined to the left quadriceps muscles. Electromyographic examination revealed continuous myoclonic discharges. Treatment with botulium toxin in the left quadriceps muscles resulted in complete cessation of pain and marked reduction in amplitude of the movements, both clinically and electromyographically. This observation indicates the efficacy of botulinum toxin in the treatment of painful spinal myoclonus.
📜 SIMILAR VOLUMES